Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Collegium Pharmaceutical, Inc. (COLL) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$780.57M |
|
$62.87M |
|
$317.31M |
|
$463.26M |
|
$600.93M |
|
$179.64M |
|
$-87.02M |
|
$92.62M |
|
$92.62M |
|
$62.87M |
|
$62.87M |
|
$62.87M |
|
$62.87M |
|
$179.64M |
|
$404.64M |
|
31.71M |
|
39.70M |
|
$1.98 |
|
$1.73 |
|
| Balance Sheet Financials | |
$691.41M |
|
$12.01M |
|
$965.42M |
|
$1.66B |
|
$440.03M |
|
$780.33M |
|
$915.13M |
|
$1.36B |
|
$301.68M |
|
$-513.76M |
|
$301.68M |
|
31.71M |
|
| Cash Flow Statement Financials | |
$329.32M |
|
$-63.53M |
|
$-110.25M |
|
$96.61M |
|
$252.16M |
|
$155.55M |
|
$41.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.57 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
0.72 |
|
2.68 |
|
59.35% |
|
23.01% |
|
23.01% |
|
51.84% |
|
11.87% |
|
8.05% |
|
$327.58M |
|
-- |
|
-- |
|
-- |
|
0.47 |
|
7.76 |
|
3.69 |
|
98.82 |
|
20.84% |
|
-12.24% |
|
3.79% |
|
5.81% |
|
$9.51 |
|
$8.25 |
|
$8.29 |
|